Literature DB >> 19899815

Expanding the utility of beta-galactosidase complementation: piece by piece.

Ann-Marie Broome1, Nihir Bhavsar, Gopalakrishnan Ramamurthy, Gail Newton, James P Basilion.   

Abstract

The ability to image and quantify multiple biomarkers in disease necessitates the development of split reporter fragment platforms. We have divided the beta-galactosidase enzyme into unique, independent polypeptides that are able to reassemble and complement enzymatic activity in bacteria and in mammalian cells. We created two sets of complementing pairs that individually have no enzymatic activity. However, when brought into close geometric proximity, the complementing pairs associated resulting in detectable enzymatic activity. We then constructed a stable ligand complex composed of reporter fragment, linker, and targeting moiety. The targeting moiety, in this case a ligand, allowed cell surface receptor targeting in vitro. Further, we were able to simultaneously visualize two cell surface receptors implicated in cancer development, epidermal growth factor receptor and transferrin receptor, using complementing pairs of the ligand-reporter fragment complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19899815      PMCID: PMC2835542          DOI: 10.1021/mp900188e

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  57 in total

1.  Detection of protein-protein interactions by protein fragment complementation strategies.

Authors:  S W Michnick; I Remy; F X Campbell-Valois; A Vallée-Bélisle; J N Pelletier
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Protein-protein interactions monitored in mammalian cells via complementation of beta -lactamase enzyme fragments.

Authors:  Tom Wehrman; Benjamin Kleaveland; Jeng-Horng Her; Robert F Balint; Helen M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 3.  Molecular genetic risk screening.

Authors:  Wayne W Grody
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

4.  [THE PROMOTOR, A GENETIC ELEMENT NECESSARY TO THE EXPRESSION OF AN OPERON].

Authors:  F JACOB; A ULLMAN; J MONOD
Journal:  C R Hebd Seances Acad Sci       Date:  1964-03-16

5.  Developing a sustainable process to provide quality control materials for genetic testing.

Authors:  Bin Chen; Catherine D O' Connell; D Joe Boone; Jean A Amos; Jeanne C Beck; Maria M Chan; Daniel H Farkas; Roger V Lebo; Carolyn Sue Richards; Benjamin B Roa; Lawrence M Silverman; David E Barton; Bassem A Bejjani; Dorothy R Belloni; Susan H Bernacki; Michele Caggana; Patricia Charache; Elisabeth Dequeker; Andrea Ferreira-Gonzalez; Kenneth J Friedman; Carol L Greene; Wayne W Grody; William Edward Highsmith; Cecelia S Hinkel; Lisa V Kalman; Ira M Lubin; Elaine Lyon; Deborah A Payne; Victoria M Pratt; Elizabeth Rohlfs; Clark A Rundell; Erasmus Schneider; Ann M Willey; Laurina O Williams; James C Willey; Emily S Winn-Deen; Daynna J Wolff
Journal:  Genet Med       Date:  2005-10       Impact factor: 8.822

6.  Identifying cytoplasmic proteins that affect receptor clustering using fluorescence resonance energy transfer and RNA interference.

Authors:  Deepak Dibya; Suzanne Sander; Emily A Smith
Journal:  Anal Bioanal Chem       Date:  2009-10-06       Impact factor: 4.142

7.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.

Authors:  Dominique B Hoelzinger; Luigi Mariani; Joachim Weis; Tanja Woyke; Theresa J Berens; Wendy S McDonough; Andrew Sloan; Stephen W Coons; Michael E Berens
Journal:  Neoplasia       Date:  2005-01       Impact factor: 5.715

8.  Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy.

Authors:  Tie Fu Liu; Stephen B Tatter; Mark C Willingham; Mitchell Yang; Jennifer J Hu; Arthur E Frankel
Journal:  Mol Cancer Ther       Date:  2003-08       Impact factor: 6.261

9.  In vivo imaging of beta-galactosidase activity using far red fluorescent switch.

Authors:  Ching-Hsuan Tung; Qing Zeng; Khalid Shah; Dong-Eog Kim; Dawid Schellingerhout; Ralph Weissleder
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

10.  Receptor-mediated endocytosis of transferrin at the blood-brain barrier.

Authors:  R L Roberts; R E Fine; A Sandra
Journal:  J Cell Sci       Date:  1993-02       Impact factor: 5.285

View more
  8 in total

1.  A fluorogenic probe for β-galactosidase activity imaging in living cells.

Authors:  Junyan Han; Myung Shin Han; Ching-Hsuan Tung
Journal:  Mol Biosyst       Date:  2013-09-19

2.  Directed Evolution of Split APEX2 Peroxidase.

Authors:  Yisu Han; Tess Caroline Branon; Jeffrey D Martell; Daniela Boassa; David Shechner; Mark H Ellisman; Alice Ting
Journal:  ACS Chem Biol       Date:  2019-03-08       Impact factor: 5.100

3.  Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.

Authors:  Suraj Dixit; Kayla Miller; Yun Zhu; Emilie McKinnon; Thomas Novak; Malcolm E Kenney; Ann-Marie Broome
Journal:  Mol Pharm       Date:  2015-08-24       Impact factor: 4.939

4.  Optical imaging of targeted β-galactosidase in brain tumors to detect EGFR levels.

Authors:  Ann-Marie Broome; Gopal Ramamurthy; Kari Lavik; Alexander Liggett; Ian Kinstlinger; James Basilion
Journal:  Bioconjug Chem       Date:  2015-03-30       Impact factor: 4.774

Review 5.  Surveying the landscape of optogenetic methods for detection of protein-protein interactions.

Authors:  Matthew D Wiens; Robert E Campbell
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-01-15

6.  Developing a far-red fluorogenic beta-galactosidase probe for senescent cell imaging and photoablation.

Authors:  Seung Koo Lee; Zhenhua Shen; Myung Shin Han; Ching-Hsuan Tung
Journal:  RSC Adv       Date:  2022-02-04       Impact factor: 3.361

7.  De novo engineering of intracellular condensates using artificial disordered proteins.

Authors:  Michael Dzuricky; Bradley A Rogers; Abdulla Shahid; Paul S Cremer; Ashutosh Chilkoti
Journal:  Nat Chem       Date:  2020-08-03       Impact factor: 24.427

8.  Synthesis and evaluation of MR probes for targeted-reporter imaging.

Authors:  Kirti Dhingra Verma; Justin O Massing; Sarah G Kamper; Christiane E Carney; Keith W MacRenaris; James P Basilion; Thomas J Meade
Journal:  Chem Sci       Date:  2017-06-13       Impact factor: 9.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.